Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ophiopogonin D
Cat. No.:
0225LY-0833
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Ophiopogonin D is a natural product that induces CYP2J3 and significantly hinders the nuclear translocation of NF-kappaB induced by Ang II.
Synonym:
945619-74-9
CAS No.:
945619-74-9
Formula:
C44H70O16
Formula Weight:
855.02
Specification
Relative Density:
1.4 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ophiopogonin D can be used in cardiovascular pharmacology to investigate its protective effects against myocardial injury and inflammation.
Library Information
Target:
RAAS; Calcium channel; NF-κB; PPAR
Receptor:
Angiotensin II receptor; Calcium channel; NF-κB; PPAR
Pathways:
Endocrinology/Hormones; NF-κB; Metabolism; DNA damage/DNA repair; Membrane transporter/Ion channel
Plate Number:
AOCL-11
Plate Location:
g2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
30 mg/mL; 35.09 mM
